Stocks and Investing Stocks and Investing
Fri, April 29, 2022

David Lebowitz Maintained (ALNY) at Strong Buy with Decreased Target to $211 on, Apr 29th, 2022


Published on 2024-10-27 20:44:36 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Citigroup, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Decreased Target from $223 to $211 on, Apr 29th, 2022.

David has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $400 on, Tuesday, April 12th, 2022
  • Etzer Darout of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $170 on, Thursday, February 3rd, 2022
  • Edward Tenthoff of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $208 on, Monday, January 3rd, 2022
Contributing Sources